TITLE

Comparison of the effect of corticosteroid therapy and decongestant on reducing rhinoplasty edema

AUTHOR(S)
Saedi, Babak; Sadeghi, Mohammad; Fekri, Khaveh
PUB. DATE
July 2011
SOURCE
American Journal of Rhinology & Allergy;Jul/Aug2011, Vol. 25 Issue 4, p141
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Comparison of the two methods of decongestant and three doses of dexamethasone on reducing edema and ecchymosis after septorhinoplasty. Methods: Seventy-four patients who were candidates for rhinoplasty were randomly divided into three groups. Group A received 8 mg of i.v. dexamethasone preoperatively and again after 24 and 48 hours after surgery, group B received three pseudoephedrine tablets (60 mg) per day for 1 week, and group C received three pseudoephedrine tablets (60 mg) per day for 2 weeks. Finally, their effects on the eye, tip and dorsal edema, and ecchymosis were evaluated. Results: Our findings showed that both decongestant and corticosteroid had significant short-term effects on edema and ecchymosis, but only continuation of pseudoephedrine could reduce the evaluated variables after 1 week. Conclusion: Pseudoephedrine can be effective for reducing eyelid edema and ecchymosis after rhinoplasty. Also, administration of three doses of dexamethasone in the postoperative care of nasal plastic surgery harmlessly diminished postsurgical edema.
ACCESSION #
62541146

 

Related Articles

  • Dexamethasone-Cyclophosphamide Pulse Therapy in Pemphigus: A Review of 72 Cases. Zivanovic, Dubravka; Medenica, Ljiljana; Tanasilovic, Srdjan; Vesic, Sonja; Skiljevic, Dusan; Tomovic, Maja; Nikolic, Milos M. // American Journal of Clinical Dermatology;2010, Vol. 11 Issue 2, p123 

    Background: Autoimmune pemphigus is a group of severe blistering diseases. Although corticosteroids have dramatically altered the prognosis of pemphigus, morbidity and mortality resulting from the adverse effects of systemic corticosteroids remain high. Dexamethasone-cyclophosphamide pulse (DCP)...

  • Bortezomib.  // Reactions Weekly;10/13/2007, Issue 1173, p8 

    The article describes the case of a 49-year-old man who developed neutrophilic dermatitis during treatment with bortezomib for multiple myeloma. Dosage and treatment cycle of bortezomib as well as the progress on the symptoms is presented. Bortezomib treatment was discontinued and he received a...

  • Effects of Different Corticosteroids on Edema and Ecchymosis in Open Rhinoplasty. Gurlek, Ali; Fariz, Alpay; Aydogan, Hakan; Ersoz-Ozturk, Ayse; Eren, Ahmet // Aesthetic Plastic Surgery;Mar2006, Vol. 30 Issue 2, p150 

    A double-blind, randomized trial with placebo control was planned to evaluate the effects of corticosteroids (betamethasone, dexamethasone, methylprednisolone) in approximately equivalent doses (8 mg dexamethasone/day), and to compare their effects with that of tenoxicam, an antiinflammatory...

  • Visual and anatomical outcomes of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids. Rebolleda, Gema; Pérez-López, Marta; Casas-LLera, Pilar; Contreras, Inés; Muñoz-Negrete, Francisco // Graefe's Archive of Clinical & Experimental Ophthalmology;Jan2013, Vol. 251 Issue 1, p255 

    Background: To evaluate the visual and anatomic outcomes after systemic steroid treatment in non-arteritic anterior ischemic optic neuropathy (NAION). Methods: Ten eyes from ten patients diagnosed with NAION and treated during the acute phase with 80 mg daily, tapering-down dose of...

  • Measurement of Inhaled Corticosteroid Adherence in Inner-City, Minority Children with Persistent Asthma by Parental Report and Integrated Dose Counter. Reznik, Marina; Ozuah, Philip O. // Journal of Allergy;2012, p1 

    Parents often overreport adherence to asthma treatment regimens making accurate assessment of medication adherence in clinical practice difficult. This study was conducted to compare two adherence assessment methods clinicians may choose from when assessing patient inhaled corticosteroid (ICS)...

  • Steroids in the Treatment of Bone Pain #129. Weinstein, Elizabeth; Arnold, Robert M. // Journal of Palliative Medicine;Jul2010, Vol. 13 Issue 7, p894 

    The article discusses the use of corticosteroids in painful bone metastases treatment. It states that the dosage for corticosteroids is considered to come from opinions of medical experts and case series such as 16 mg of oral methylprednisolone for cancer-related pain. It adds that the side...

  • ADRENOCORTICOIDS (Topical). GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2011, p18 

    The article presents information on adrenocorticoids, a topical drug developed to treat swelling, itching, skin discomfort, hair loss and other medical problems, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • O2–055RANDOMIZED PHASE III TRIAL OF APREPITANT COMPARED WITH DEXAMETHASONE FOR EMESIS INDUCED BY CARBOPLATIN. Daga, H.; Kinbara, S.; Katsushima, U.; Okada, H.; Tsuya, A.; Taira, K.; Tokunaga, S.; Nakao, M.; Yoshida, T.; Takeda, K. // Annals of Oncology;Nov2013 Supplement 9, Vol. 24, pix51 

    No abstract available.

  • A Preliminary Evaluation of Dexamethasone Palmitate Emulsion: A Novel Intravitreal Sustained Delivery of Corticosteroid for Treatment of Macular Edema. Daull, Philippe; Paterson, Christopher A.; Kuppermann, Baruch D.; Garrigue, Jean-Sébastien // Journal of Ocular Pharmacology & Therapeutics;Mar2013, Vol. 29 Issue 2, p258 

    Purpose: Dexamethasone palmitate (DXP) is a lipophilic prodrug of dexamethasone (DXM), a potent corticosteroid used to treat a variety of ophthalmic diseases. The aim of the study was to characterize the sustained release capacity (in rabbit), efficacy (in rat and rabbit), and safety (in rabbit,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics